Literature DB >> 19349865

Treatment of radiation retinopathy following plaque brachytherapy for choroidal melanoma.

Joanne C Wen1, Tara A McCannel.   

Abstract

PURPOSE OF REVIEW: Radiation retinopathy and maculopathy are predictable complications resulting from exposure to any source of radiation, including external beam and plaque brachytherapy. Most choroidal melanomas are currently treated with plaque brachytherapy. However, the ensuing complications frequently compromise posttreatment vision. The purpose of this review is to discuss recent studies on the management of radiation retinopathy and maculopathy. RECENT
FINDINGS: Intravitreal bevacizumab, intravitreal triamcinolone and laser photocoagulation appear to transiently decrease macular edema, although improvements in visual acuity are limited. In successful studies, recurrent treatments were needed to sustain the effects. Case studies of photodynamic therapy, oral pentoxyphylline and hyperbaric oxygen treatment describe positive results, but further studies are required. One study suggests that laser photocoagulation may be useful in prophylactically treating radiation retinopathy.
SUMMARY: Currently, there are no proven treatments for radiation retinopathy or maculopathy. The current treatment methods require frequent administration with variable improvement in visual acuity.

Entities:  

Mesh:

Year:  2009        PMID: 19349865     DOI: 10.1097/ICU.0b013e328329b62d

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  7 in total

1.  23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.

Authors:  Tara A McCannel; Mitchell Kamrava; Jeffrey Demanes; James Lamb; John D Bartlett; Robert Almanzor; Melissa Chun; Colin A McCannel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-16       Impact factor: 3.117

2.  Multiple Pigmented Conjunctival Lesions following Intravitreal Injections in a Patient with Uveal Melanoma.

Authors:  Niels J Brouwer; Gregorius P M Luyten; Sjoerd G van Duinen; Martine J Jager; Marina Marinkovic
Journal:  Ocul Oncol Pathol       Date:  2016-11-09

3.  Bevacizumab in vitreous haemorrhage secondary to radiation retinopathy.

Authors:  Javier Antonio Montero; Giovanni Yanez-Castro; Maria Eugenia Sanchis-Merino; Jose Maria Ruiz-Moreno
Journal:  BMJ Case Rep       Date:  2014-02-07

4.  Longitudinal Detection of Radiation-Induced Peripapillary and Macular Retinal Capillary Ischemia Using OCT Angiography.

Authors:  Alison H Skalet; Liang Liu; Christina Binder; Audra K Miller; Richard Crilly; Arthur Y Hung; David J Wilson; David Huang; Yali Jia
Journal:  Ophthalmol Retina       Date:  2019-10-11

5.  Serial Intravitreal Bevacizumab Injections Slow the Progression of Radiation Maculopathy Following Iodine-125 Plaque Radiotherapy.

Authors:  Andrew W Stacey; Hakan Demirci
Journal:  Open Ophthalmol J       Date:  2016-03-15

6.  Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients.

Authors:  Lance J Lyons; Ethan D Hinds; Sarada Chexal; Brian Berger
Journal:  Cureus       Date:  2019-07-29

7.  Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.

Authors:  Michael Chang; Lauren A Dalvin; Mehdi Mazloumi; Andrei Martin; Antonio Yaghy; Xiaolu Yang; Saba Bakhtiari; Lucy Li; Erin Jennings; Arman Mashayekhi; Carol L Shields
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2020 Jan-Feb
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.